Genic and Biotech Growth Leverage Teva’s strong generic and biosimilars footprint to position companion services, contract manufacturing partnerships, and co-development opportunities that complement their large-scale generic portfolio and potential biosimilar launches.

Neuroscience Focus Target Teva’s expanding neuroscience assets and pipeline by offering specialized clinical development support, regulatory strategizing, and manufacturing scale-up services for complex neuropharmacological products.

Strategic Acquisitions capitalize on Teva’s active asset expansion, including neuroscience portfolios, by presenting value-add potential through asset integration services, transition planning, and manufacturing synchronization for acquired products.

Global Commercial Scale With a 10001+ employee base and multi-regional presence, propose end-to-end commercial support, market access optimization, and global supply chain resilience solutions to sustain Teva’s broad commercial reach.

Financial Readiness Position high-value partnerships around capital-efficient development, manufacturing optimization, and risk-managed commercialization to align with Teva’s substantial revenue scale and funding capacity.